JAK inhibitor blocks COVID-19 cytokine–induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids-Reference-Cited by-同舟云学术

JAK inhibitor blocks COVID-19 cytokine–induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids

Published:2022-06-08 Issue:11 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Nystrom Sarah E.^ORCID,Li Guojie,Datta Somenath,Soldano Karen L.,Silas Daniel,Weins Astrid^ORCID,Hall Gentzon^ORCID,Thomas David B.,Olabisi Opeyemi A.^ORCID

Funder

NIH

Duke University

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/157432/files/pdf

Reference45 articles.

1. AKI in Hospitalized Patients with COVID-19

2. Acute kidney injury in patients hospitalized with COVID-19

3. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19)

4. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL1 High-Risk Genotype

5. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1–Mediated Kidney Disease (JUSTICE);Kidney International Reports;2024-09

2. APOL1 High-Risk Genotype is Not Associated With New or Worsening of Proteinuria or Kidney Function Decline Following COVID-19 Vaccination;Kidney International Reports;2024-09

3. APOL1 Nephropathy Risk Variants Through the Life Course: A Review;American Journal of Kidney Diseases;2024-07

4. An Update on Viral Infection-Associated Collapsing Glomerulopathy;Advances in Kidney Disease and Health;2024-07

5. Focal Segmental Glomerulosclerosis;Advances in Kidney Disease and Health;2024-07